tiprankstipranks
Eloxx Pharmaceuticals (ELOX)
NASDAQ:ELOX
US Market
ELOX
Eloxx Pharmaceuticals
RESEARCH TOOLSreports
Want to see ELOX full AI Analyst Report?

Eloxx Pharmaceuticals (ELOX) Financial Statements

305 Followers

Eloxx Pharmaceuticals Financial Overview

Eloxx Pharmaceuticals's market cap is currently $60.55M. The company's EPS TTM is $-1.52; its P/E ratio is -9.87; Eloxx Pharmaceuticals is scheduled to report earnings on August 12, 2026, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 6.36M$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 6.36M$ 0.00$ -695.00K$ -960.00K
Operating Income$ -6.44M$ -2.47M$ -17.29M$ -34.42M$ -42.35M
EBITDA$ -4.95M$ -1.83M$ -15.09M$ -33.50M$ -64.51M
Net Income$ -6.00M$ -3.14M$ -17.05M$ -36.06M$ -66.73M
Balance Sheet
Cash & Short-Term Investments$ 4.79M$ 111.00K$ 1.13M$ 19.47M$ 42.57M
Total Assets$ 5.27M$ 2.98M$ 1.71M$ 21.12M$ 45.14M
Total Debt$ 1.00M$ 6.52M$ 3.97M$ 13.38M$ 13.46M
Net Debt$ -3.79M$ 6.41M$ 2.83M$ -6.08M$ -29.11M
Total Liabilities$ 17.18M$ 27.31M$ 24.31M$ 31.78M$ 22.75M
Stockholders' Equity$ -11.91M$ -24.34M$ -22.60M$ -10.66M$ 22.38M
Cash Flow
Free Cash Flow$ 0.00$ -4.71M$ -14.34M$ -31.91M$ -35.09M
Operating Cash Flow$ -6.33M$ -4.71M$ -14.34M$ -31.84M$ -35.00M
Investing Cash Flow$ 1.00K$ 38.00K$ 309.00K$ -66.00K$ 2.06M
Financing Cash Flow$ 11.00M$ 3.44M$ -4.08M$ 8.81M$ 50.79M
Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History

Income Statement >

Eloxx Pharmaceuticals Debt to Assets

Balance Sheet >

Eloxx Pharmaceuticals Cash Flow

Cash Flow >

Eloxx Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >